Skip to main content

What the FDA labels say about taking them together

Etravirine and macimorelin

Macimorelin's FDA label of February 18, 2026 names etravirine in its drug interactions section; the etravirine label PlainMeds reads does not name macimorelin. The macimorelin label: “Cytochrome P450 (CYP) 3A4 Inducers Co-administration of a strong CYP3A4 inducer with MACRILEN may reduce the plasma macimorelin concentrations and may lead to false positive test results.”

Check it at the source: the etravirine FDA label on DailyMed (effective August 15, 2023, Janssen Products LP); the macimorelin FDA label on DailyMed (effective February 18, 2026, Aeterna Zentaris GmbH).

What does the etravirine label say about macimorelin?

Etravirine's label (effective August 15, 2023) does not name macimorelin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Intelence), Janssen Products LP, effective August 15, 2023 (SPL set 6a9cbc29-9f15-4b24-8d86-206b82887f3d), via openFDA; the full label on DailyMed

What does the macimorelin label say about etravirine?

Macimorelin label, drug interactions

Cytochrome P450 (CYP) 3A4 Inducers Co-administration of a strong CYP3A4 inducer with MACRILEN (e.g., carbamazepine, enzalutamide, mitotane, phenytoin, rifampin, St. John's wort, bosentan, efavirenz, etravirine, modafinil, armodafinil, rufinamide) may reduce the plasma macimorelin concentrations and may lead to false positive test results.

Source: FDA drug label (Macrilen), Aeterna Zentaris GmbH, effective February 18, 2026 (SPL set aeb30f1a-4815-47ae-a2cb-b6b4e26372e1), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Etravirine generic labelers
0Macimorelin generic labelers
EtravirineMacimorelin
Labeled forHIVn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$9.94 per tablet 200 mg tabletn/a
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?